Kaplan-Meier curves of univariate analysis data (log-rank test).

<p>(a) The overall survival (OS) of the patients without lymph node metastasis with high versus low B3GNT3 expression. (b) The OS for the patients with squamous cell carcinoma antigen > 1.5ng/ml with high versus low B3GNT3 expression. (c) The OS for the patients with HPV infection with high versus low B3GNT3 expression. (d) The OS for the patients with deep stromal invasion with high versus low B3GNT3 expression. (e) The OS for the patients at stages Ib1-Ib2 with high versus low B3GNT3 expression. (f) The OS for the patients at stages IIa1-IIa2 with high versus low B3GNT3 expression. (g) The OS for the patients at differentiation 1–2 with high versus low B3GNT3 expression. (h) The OS for the patients at differentiation 2–3 with high versus low B3GNT3 expression. (i) The OS for the patients with high versus low B3GNT3 expression who received chemotherapy.